BACKGROUND: The COVID-19 pandemic determines the functioning of the healthcare system. The epidemic of HIV infection depends heavily on the effectiveness of the health system and its ability to test and deliver prevention and treatment. This study aims to determine the consequences of this pandemic on the development of HIV infection testing in the Czech Republic. METHODS: A descriptive cross-sectional study analyzed data for two infectious diseases, HIV (2020 and 2015-2019) and COVID-19 (2020), in the Czech Republic. For the statistical comparison of 2020 with the earlier period, the Incidence Rate Ratio (IRR) and Poisson regression methods were used. Monthly HIV and COVID-19 indicators for 2020 were analyzed using correlation analysis. RESULTS AND DISCUSSION: A significant difference was observed only in April (IRR = 0.81; p = 0.046) and July (IRR = 1.27; p = 0.023) between the number of HIV tests performed in each month in 2020 and the control period (average for the same months of the period 2015-2019). Significant differences between the observed periods were further identified for testing reasons. Correlation analysis of the number of tests performed on HIV and COVID-19 after 2020 showed a negative relationship (r = -0.261, p = 0.412). CONCLUSION: The study did not confirm statistically significant differences between the number of HIV tests performed in the pandemic year 2020 compared to the previous period, except for two months. The incidence and number of newly diagnosed cases did not differ statistically significantly from previous years (2015-2019).

3rd Faculty of Medicine Charles University Na Bulovce University Hospital Prague Czech Republic

Faculty of Science Charles University Prague Czech Republic

Zobrazit více v PubMed

Wang C.; Horby P.W.; Hayden F.G.; Gao G.F.; A novel coronavirus outbreak of global health concern. Lancet 2020,395(10223),470-473 PubMed DOI

Huang C.; Wang Y.; Li X.; Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020,395(10223),497-506 PubMed DOI

The epidemiological situation will be newly represented by the PES evaluation system Ministry of Health of the Czech RepublicAvailable from:

Emergency Ministry of the Interior Medical FacilityAvailable from:

COVID-19 in the Czech Republic: Open data sets and downloadable sets. Ministry of Health of the Czech RepublicAvailable from:

Information Handbook for HIV / AIDS Prevention and for the Promotion of HIV Testing. Hygiene Station of the Capital City of PragueAvailable from:

Emergency measures, COVID-19. State Institute of Public HealthAvailable from:

Jenness S.M.; Guillou A.L.; Chandra C.; Projected HIV and bacterial STI incidence following COVID-related sexual distancing and clin-ical service interruption. MedRxiv 2021,223(6),1019-1028 DOI

Lesosky M.; Myer L.; Modelling the impact of COVID-19 on HIV. Lancet HIV 2020,7(9),e596-e598 PubMed DOI

Shiau S.; Krause K.D.; Valera P.; Swaminathan S.; Halkitis P.N.; The burden of COVID-19 in people living with HIV: A syndemic perspective. AIDS Behav 2020,24(8),2244-2249 PubMed DOI

Sanchez T.H.; Zlotorzynska M.; Rai M.; Baral S.D.; Characterizing the impact of COVID-19 on men who have sex with men across the United States in April, 2020. AIDS Behav 2020,24(7),2024-2032 PubMed DOI

Mitchell K.M.; Dimitrov D.; Silhol R.; The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortali-ty among men who have sex with men in the USA: A modelling study. Lancet HIV 2021,8(4),e206-e215 PubMed DOI

Tamuzi J.L.; Ayele B.T.; Shumba C.S.; Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evi-dence. BMC Infect Dis 2020,20(1),744 PubMed DOI

Lesko C.R.; Bengtson A.M.; HIV and COVID-19: Intersecting epidemics with many unknowns. Am J Epidemiol 2021,190(1),10-16 PubMed DOI

Noe S.; Schabaz F.; Helwein S.; HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German ‘hotspot’. Infection 2021,49(2),313-320

Kalichman S.C.; Eaton L.A.; Berman M.; Kalichman M.O.; Katner H.; Sam S.S.; Caliendo A.M.; Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living With HIV, Atlanta, Georgia. J Acquired Immune Defi. Synd 2020,85(1),66-72 DOI

At the Intersection of two pandemics: the impact of COVID-19 on HIV. Available from:

Annual reports on the incidence and spread of HIV / AIDS. State Institute of Public HealthAvailable from:

Michielsen K.; Larrson E.C.; Kagesten A.; International Sexual Health and REproductive Health (I-SHARE) survey during COVID-19: Study protocol for online national surveys and global comparative analyzes. Sex Transm Infect 2021,97,88-92 PubMed

Davies M-A.; HIV and risk of COVID-19 death: A population cohort study from the Western Cape Province, South Africa. MedRxiv 2020 DOI

Hyndman I.; Nugent D.; Whitlock G.G.; McOwan A.; Girometti N.; COVID-19 restrictions and changing sexual behaviors in HIV-negative MSM at high risk of HIV infection in London, UK. Sex Transm Infect 2021,97(7),521-524

Suwanwongse K.; Shabarek N.; Variation in mortality of HIV/SARS-CoV-2 coinfected patients in the Bronx, New York City. J Med Virol 2021,93(2),603-605 PubMed DOI